LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3
Open Access
- 12 August 2018
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 109 (10) , 3068-3079
Abstract
Over the past several years, long non‐coding RNAs (lncRNAs) have attracted more and more attention due to their special functions. They are vital biomarkers in multiple diseases. LncRNA HOMEOBOX A11 (HOXA11) has been found to be aberrantly expressed in some kinds of malignant tumors. In this study, we mainly discuss the oncogenic role of it in promoting malignant progression and chemoresistance in lung adenocarcinoma (LUAD) cells. The expression of HOXA11‐AS was much stronger in cisplatin‐resistant LUAD cells. Based on The Cancer Genome Atlas database, patients with high expression of HOXA11‐AS had shorter survival time. Additionally, knockdown of HOXA11‐AS caused positive changes in cell activities of LUAD. For example, cell proliferation and migration were weakened, the epithelial mesenchymal transition process was reversed, and apoptosis was induced. These changes were more obvious in cells treated with cisplatin. Next, the HOXA11‐AS/miR‐454‐3p/Stat3 (signal transducer and activator of transcription 3) pathway was found to influence the cisplatin resistance of LUAD cells. HOXA11‐AS specifically acted as a competing endogenous RNA (ceRNA) in LUAD cells. The combinations among these three genes were demonstrated. Finally, rescue assays were applied to demonstrate the ceRNA pattern consisting of HOXA11‐AS, miR‐454‐3p and Stat3. In conclusion, lncRNA HOXA11‐AS acted as a ceRNA to promote cisplatin resistance of human LUAD cells via the miR‐454‐3p/Stat3 axis.Keywords
Funding Information
- National Natural Science Foundation of China (81372396, 81570186)
This publication has 28 references indexed in Scilit:
- MiR-429 regulates gastric cancer cell invasiveness through ZEB proteinsTumor Biology, 2015
- MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial–mesenchymal transitionCancer Letters, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide AntagonistCancer Research, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like SignaturePLOS ONE, 2013
- MiRNA-429 suppresses the growth of gastric cancer cells in vitroJournal of Biomedical Research, 2012
- Trends in incidence of small cell lung cancer and all lung cancerLung Cancer, 2012
- Molecular pathology of lung cancer: key to personalized medicineLaboratory Investigation, 2012
- Identification of novel sense and antisense transcription at the TRPM2 locus in cancerCell Research, 2008